October 1, 2026
ArkeaBio
ArkeaBio, a Boston-based developer of a vaccine to cut livestock methane emissions, raised $15 million in Series A extension funding.
- Round
- Series A
- Amount raised
- $15M
- Lead investor
- AgriZeroNZ
- Industry
- Biotech (livestock methane vaccine)
- Headquarters
- Boston
- Employees
- 11-50 employees
- Website
- arkeabio.com
- View profile →
Other investors
- Breakthrough Energy
Source: Axios Pro Rata